• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • France

Keensight scores 12x on final LDR exit

  • José Rojo
  • José Rojo
  • 08 April 2015
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Keensight Capital has fully sold its participation in listed French spinal implant device designer LDR Medical.

The divestment yielded 12x returns for Keensight against its initial investment in 2005, and 3x against its re-investment in the run-up to the company's IPO.

LDR raised $75m on the Nasdaq following its listing in October 2013. The IPO saw the company sell 5 million shares at $15 apiece, with an over-allotment option of 750,000 shares.

LDR Medical

  • DEAL:

    Exit

  • LOCATION:

    Troyes

  • SECTOR:

    Medical equipment

  • FOUNDED:

    2000

  • TURNOVER:

    $141m

  • VENDOR:

    Keensight Capital

After the flotation, Keensight remained the company's largest shareholder with a 16.4% stake – down from 21.1%. Meanwhile, co-investors Austin Ventures, Telegraph Hill Partners and PTVSciences retained holdings of 14.3%, 13.5% and 8.8%, respectively.

LDR stated it would use the proceeds of the listing to finance the production and marketing of a new product backed by the US Food and Drug Administration.

The company also sought to repay the debt facility supplied by Escalate Capital Partners, according to LDR's Securities and Exchange Commission S-1 filing.

This is the third divestment in recent months by Keensight, which reported 5x returns over the two previous deals. These included Italian telematics service provider Octo and software developer FircoSoft.

In addition, the firm invested in French orthopaedic prostheses and dental implants supplier Menix in April 2014. The buyout, also featuring capital from CIC Finance and Turenne Capital Partennaires, is thought to have been valued at between €25-50m.

Previous funding
Keensight acquired LDR in 2005 via its fund II, with mezzanine debt supplied by Escalate Capital Partners and then refinanced via senior debt from Comerica. The GP later drew capital from its fund III to reinvest in the company in the run-up to its IPO.

According to market sources, a total of €10m was injected into LDR since the first investment took place in 2005. 

Company
Founded in 2000, LDR is a designer and developer of spinal implant devices designed to facilitate spinal surgery procedures. Headquartered in Troyes, France, its network of offices extends to Austin in the US, as well as Sao Paulo, Seoul and Beijing.

The business claims to have increased its turnover from $91m in 2012 to $141m in 2014, two-thirds of which come from the US.

People
Keensight Capital was represented by managing partner Pierre Rémy. Christophe Lavigne, Hervé Dinville and Patrick Richard are LDR's founding managers.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • France
  • Exits
  • France
  • IPO

More on France

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Mergermarket
Letter from the editor: Unquote is moving to Mergermarket

Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers

  • Industry
  • 30 August 2023
Pensions administration software providers
IK Investment-backed Eres expected to hit the auction block by 2024

French employee savings distribution and management firm could be valued at a few hundred million euros

  • Exits
  • 24 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013